Release date: 30 May 2024
Promoter – Financial Intermediary
MEDACCESS GUARANTEE LTDLocation
Description
The project will support health systems by enabling MedAccess to provide volume and procurement guarantees for essential medical supplies. The pipeline includes the purchase of vaccines as well as eligible investments in innovation and manufacturing scale-up.
Objectives
The aim is to increase the access and availability of medicinal products, including vaccines, for the benefit of low- and middle-income countries thus reducing the burden of endemic diseases and malnutrition.
Sector(s)
- Health - Human health and social work activities
Under Global Europe NDICI guarantee
Under EFSD+ Guarantee
Proposed EIB finance (Approximate amount)
EUR 52 million
Total cost (Approximate amount)
EUR 200 million
Environmental aspects
The implementation of the project will be done in line with the principles of EU environmental legislation and EIB Environmental and Social Standards.
Procurement
The Bank will require that implementation of the project needs to be done in accordance with the EIB's Guide to Procurement.
Status
Under appraisal - 26/03/2024
Disclaimer
Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).